Short biography
1984 until 1989 | Study of pharmacy at the Ludwig-Maximilians-University Munich, licence to practise pharmacy
1989 until 1999 | Employed pharmacist in various public pharmacies
1990 until 1993 | Independent management of a public pharmacy
1994 until 1996 | Postgraduate course in Public Health and Epidemiology. LMU Munich. Master of Public Health (MPH)
1999 | Doctorate as Dr. rer. hum. biol. at the Medical Faculty of the LMU Munich
Topic: »The prophylaxis of neural tube defects by folic acid: putting a medical research result into practice«
1999 until 2001 | Research associate in the research project »Pegasus« on drug intake during pregnancy at the Bavarian Research Association for Public Health
2001 until 2004 | Research associate in a study of the German Research Foundation (DFG): »Analysis of health insurance data on drug prescription in pregnancy«
Since 2005 | Research associate at PMV research group
Work focus
- Drug application research (pharmacoepidemiology)
- Evaluation of drug and health data of the statutory health insurance
- Health Services Research
Memberships
- Society for Drug Application Research and Drug Epidemiology (GAA)
- German Society for Epidemiology (DGEpi)
Selected Publications
Grandt D, Lappe V, Schubert I.
BARMER Arzneimittelreport 2020. Sektorenübergreifende Arzneimitteltherapie. BARMER Institut für Gesundheitssystemforschung - bifg (Hrsg.). Wuppertal 2020;
Grandt D, Lappe V, Schubert I.
BARMER Arzneimittelreport 2019. Impfungen bei Kindern und Jugendlichen. BARMER (Hrsg.). Wuppertal 2019;
Grandt D, Lappe V, Schubert I (Hrsg.).
Barmer Arzneimittelreport 2018. Arzneimitteltherapiesicherheit. BARMER Verlag, Wuppertal 2018;
Grandt D, Schubert I (Hrsg.).
Barmer Arzneimittelreport 2017. Schwerpunkt: Medikamentöse Tumortherapie. Asgard Verlag, Siegburg. 2017;
Lappe V, Köster I, Schubert I.
Antidiabetische Medikation in den ersten vier Therapiejahren. Eine Studie auf Basis von Krankenkassendaten. Deutsche Medizinische Wochenschrift 2017; 142: e1-e9 und Diabetes Aktuell 2017; 15: 242-256
Grandt D, Schubert I (Hrsg.).
Barmer GEK Arzneimittelreport 2016. Analysen zur Arzneimitteltherapie und Arzneimitteltherapiesicherheit. Schwerpunkt: Biotechnologisch hergestellte Arzneimittel. Band 39; Asgard Verlag, Siegburg. 2016;
Lappe V, Köster I, Schubert I.
Incidence estimate and guideline-oriented treatment for post-stroke spasticity: an analysis based on German statutory health insurance data. International Journal of General Medicine 2013; 6: 135-144
PMV
interdisciplinary team
